HENDERSON, Nev.--(BUSINESS WIRE)--Jun. 11, 2025--
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced the successful transition of 123 out of 132 newly awarded plasma donation centers. The remaining nine centers are on track to go live in the third quarter of 2025.
The onboarding of 123 centers was completed in just one week – significantly ahead of schedule – demonstrating Paysign’s operational agility, platform scalability and executional discipline.
“Successfully transitioning this volume of centers in a single week is a testament to the strength of our platform, the rigor of our processes and the exceptional capabilities of our team,” said Mark Newcomer, President and CEO of Paysign. “We delivered a seamless experience for center staff, leadership teams and donors—without disruption—setting a new benchmark for speed and precision in the industry. The addition of these centers represents a pivotal return to revenue growth for this business unit. This, combined with the continuing exceptional growth of our patient affordability business, gives us great confidence in Paysign’s forward momentum.”
This achievement reinforces Paysign’s strategic value to plasma collection organizations seeking reliable, scalable and compliant payment solutions. It also underscores the company’s continued momentum in the healthcare financial services sector and its ability to capitalize on growth opportunities with speed and efficiency.
Forward-Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. Paysign undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.
About Paysign
Paysign, Inc. is a leading provider of prepaid card programs, comprehensive patient affordability offerings, financial technology products and integrated payment processing designed for businesses, consumers and government institutions. Incorporated in 1995 and headquartered in southern Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality, and retail. Built on the foundation of a reliable payments platform, Paysign’s end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, customer incentives, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. Paysign’s solutions lower costs, streamline operations and improve customer, employee and partner loyalty. To learn more, visit paysign.com.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20250611828469/en/
Investor Relations
ir@paysign.com
888.522.4853
paysign.com/investors
Media Relations
Alicia Ches
888.522.4850
pr@paysign.com
Source: Paysign, Inc.
